November 21, 2024
Would you like to learn more about our work? If you'd happen to be in Helsinki on November 21, feel free to visit us at the Slush start-up conference. We'll be joining the delegation headed by Flanders Investment and Trade there, and have a booth at the festival on November 21.
November 17, 2024
Breaking news: ReVision has been accepted to the European Medicine Agency's orphan medical device pilot program! This program will enable a more easy market access for devices with life-altering implications for relatively small patient groups (<12.000 per year in the EU). We happen to just fit in 😊
November 1, 2024
After several years of hard work and numerous animal tests, we are confident enough in our approach to start concrete preparations for first-in-human testing of our implant. The process will have several steps: we will first do short-term testing of the electrode arrays and then move gradually towards a full long-term test of the entire system. Dr. Lara Merken is joining our team in the new role of clinical trial manager to coordinate these efforts. Thanks again to VLAIO for supporting these efforts!
October 1, 2024
We are happy to announce that the second generation of our neurostimulator chip has been taped out by our project partner KU Leuven. It is a heavily upscaled version of an earlier design that was successfully tested last year. The chip will now be manufactured by TSMC and will be ready for integration in our system early in 2025. It will be used in the first fully implantable version of our system, which will allow to address over 2000 microelectrodes in the visual cortex. Picture is for illustration only, the actual design is still confidential!
November 1, 2023
We are proud to announce we've entered in a collaboration with prof. Wim Dehaene of the MICAS research group of KU Leuven, Belgium. MICAS is a key player in research on integrated circuits, and will play an important role in further advancing the electronics required for our implants. The R&D project is supported by VLAIO in the framework of the 'StimChip' project.
October 27, 2023
We have presented our technology at the European Brain Council's Brain Innovation Days, and were awarded the 'Innovation Showcase Award'. Thanks to all that made the progress we've recently made possible!
October 12 & November 29-30, 2023
Interested in a live conversation with the ReVision team? You will have a chance to meet us in person at Slush'D, the largest gathering of start-ups and investors in the world. We will be present both at the local exhibition in Leuven as well as at the international edition in Helsinki.
October 9-10, 2023
After a year of hard work and radio silence, we will present the progress we have made at The Eye and The Chip, a conference sponsored by the Henry Ford Foundation that brings together researchers and companies in vision restauration worldwide. Thanks to dr. Hessburg for inviting us for a platform presentation!
August 28, 2023
Our 'HyperStim' EIC project was featured in this month's Horizon Magazine. Earlier this summer, we were also mentioned in the newspapers De Morgen and HLN.
November 23, 2022
Our very own Laurens Goyvaerts made a remarkable impression as keynote spead on this year's AFT Medtech Convention, leading to our booth being the most visited of the conference. Congratulations, Laurens!
April 20, 2022
We are proud to announce that, together with out partners at KULeuven (Belgium), UPF (Barcelona) and
TTK (Hungary) we have been awarded a prestigious 'Pathfinder' grant from the European Innovation Council. This 2.2 million € grant will allow us to thoroughly study the advanced neurostimulation strategies needed to enhance the resolution of visual prostheses 20X compared to the state of the art. Our sincere thanks go to the jury for supporting our vision that will allow to drastically improve treatment options for blind people worldwide!
Dec 7, 2021
ReVision and Atlas Neuroengineering, a company that builds and sells neural probes for preclinical research applicatons, submitted a joint grant proposal to the Flemish government to ask for support in further developing flexible neural electrode technology. Recently, we received news about the posititive evaluation of this proposal. We thank the jury for their trust and support. This grant will be instrumental in helping us to evaluate the long-term performance of our implants in several use cases.
November 20, 2021
We have received an excellent official search report about our first patent from the European Patent Office. This means the chance that our first patent will be awarded without much hassle is extremely high. Our sincere thanks go to the fine patent lawyers at IPLodge!
July 10, 2021
ReVision and KU Leuven are proud to announce that our colleague, Maarten Schelles, received a Baekeland PhD grant from the Flemish government. It will allow Maarten to work for 4 years on a research project that directly contributes to the further development of visual prostheses. We are more than grateful to have him in our team!
